ASDAS states in patients stratified by baseline MRI/CRP status.
Por um escritor misterioso
Descrição
Effective prognostic and clinical risk stratification in COVID‐19 using multimodality biomarkers - Liu - 2023 - Journal of Internal Medicine - Wiley Online Library
Diagnosis, Workup, Risk Reduction of Transient Ischemic Attack in the Emergency Department Setting: A Scientific Statement From the American Heart Association
Longitudinal assessment of structural phenotype in Brugada syndrome using cardiac magnetic resonance imaging - ScienceDirect
ASDAS-CRP (full analysis set). (A) Change in ASDAS-CRP score from
Evaluation of BASDAI (Panel A) and ASDAS-CRP (Panel B) during
Full article: Effectiveness of bDMARDs in ankylosing spondylitis patients by biologic use: experience from the CorEvitas PsA/SpA Registry
ASDAS states in patients stratified by baseline MRI/CRP status.
Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial - The Lancet Respiratory Medicine
JCM, Free Full-Text
Improvement in (A) ASAS20 and (B) ASAS40 response rates in patients
Precision health in Alzheimer disease: Risk assessment‐based strategies - Azar - 2021 - Precision Medical Sciences - Wiley Online Library
Midlife systemic inflammatory markers are associated with late-life brain volume
Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT, Arthritis Research & Therapy
PDF) Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long-term open-label adalimumab treatment: 3-year results of the ABILITY-1 trial
Interosseous tendon inflammation in the hands of patients with clinically suspect arthralgia: analysis of MRI data from a prospective cohort study - The Lancet Rheumatology
de
por adulto (o preço varia de acordo com o tamanho do grupo)
